Detection of basic Fibroblast Growth Factor mRNA in urinary bladder cancer: Correlation with local relapses

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1123-1127

  Gazzaniga, Paola ^a   Gandini, Orietta ^a   Gradilone, Angela ^a   Silvestri, Ida ^a   Giuliani, Laura ^a   Magnanti, Massimo ^a   Gallucci, Michele ^b   Saccani, Gloria ^c   Frati, Luigi ^a,d   Aglianò, Anna Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedale 'Cristo Re'   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

bFGF; Bladder cancer; Relapse

Indexed keywords

BETA 2 MICROGLOBULIN; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLADDER; BLADDER TUMOR; CANCER STAGING; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR RECURRENCE;

ADULT; AGED; BETA 2-MICROGLOBULIN; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0033144295     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1123     Document Type: Article

References (17)

1. Shing Y, Folkman J and Sullivan R: Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223: 1296-1299, 1984.
2. Wieder R, Wong H, Shirke S, Wang Q, Menzel T, Feirt N, Jakuboski AA and Gabrilove JL: Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15: 41-60, 1997.
3. Nguyen M, Hiroyuki W, Budson AE, Richie JP, Hayes DF and Folkman J: Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 85: 241-242, 1993.
4. Fujimoto K, Ichimori Y and Kakizoe T: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180: 386-392, 1991.
5. Nanus DM, Schmitz-Drager BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Carlo C, Albino AP and Reuter VE: Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 85: 1597-1599, 1993.
6. Nguyen M, Watanabe H and Budson AE: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-359, 1994.
7. Obermair A. Speiser P, Reisenberger K, Ullrich R, Czerwenka K, Kaider A, Zellinger R and Miksche M: Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett 130: 69-76, 1998.
8. Bochner B, Cote RJ and Weidner N: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87: 1603-1612, 1995.
9. Campbell SC, Volpert OV, Ivanovich M and Bouch NP: Molecular mediators of angiogenesis in bladder cancer. Cancer Res 58: 1298-1304, 1998.
10. Sawase K, Nomata K, Kanetake H and Saito Y: The expression of platelet-derived endothelial cell growth factor in human bladder cancer. Cancer Lett 130: 35-41, 1998.
11. Crew JP, O'Brien T, Bradburn M, Fuggle S, Bicknell R, Cranston D and Harris AL: Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57: 5281-5285, 1997.
12. O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL: Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res 57: 136-140, 1997.
13. Gazzaniga P, Gradilone A, Vercillo R, Gandini O, Silvestri I, Napolitano M, Albonici L, Vincenzoni A, Gallucci M, Frati L and Aglianò AM: bcl2/bax mRNA expression ratio as prognostic factor in low grade urinary bladder cancer. Int J Cancer 69: 100-104, 1996.
14. Philp EA, Stephenson TJ and Reed MW: Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 77: 352-357, 1996.
15. Gardner AM and Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires ras and the activation of mutagen-activated protein kinase. J Biol Chem 271: 14560-14566, 1996.
16. Konig A, Menzel T, Lynen S, Wrazel L, Rosen A, Al-Katib A, Raveche E and Gabrilove JL: Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 11: 258-265, 1997.
17. Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S and Saya H: Overexpression of bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene 16: 933-943, 1998.